Xilio Therapeutics grants inducement stock options for 107,060 shares at $9.22 each

Xilio Therapeutics Inc

Xilio Therapeutics Inc

XLO

0.00
  • Xilio Therapeutics granted non-qualified stock options for 107,060 shares to three new employees, effective July 1, 2026.
  • Exercise price set at USD 9.22 per share, matching the July 1 closing price; options carry a 10-year term.
  • Vesting schedule: 25% after one year of employment; remaining 75% vests in 36 equal monthly installments.
  • Awards were issued under the 2022 Inducement Stock Incentive Plan.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607061630PRIMZONEFULLFEED9756375) on July 06, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.